top of page

OUR FOCUS PRODUCTS

Malaria (Cerebral and Severe Malaria)

Every minute, a child under the age of 5 years, dies in Africa due to malaria. Hananja plc has developed an easy-to-use rectal enema that contains a combination of required drugs (artemether and lumefantrine). This product can be used in unconscious children and does not depend on the child being alert and able to swallow. This product is also heat stable, even if stored at high tropical temperature and will allow the treatment to be carried out in rural areas, where access to hospital settings is limited.

There is a serious need to provide an appropriate dosage form that can secure a safe and effective treatment for this age group (0-5 years). Something that can work immediately does not require refrigeration in a hot tropical climate, and is easy to use by families, caregivers, and health professionals, even in rural areas in Africa. Together with the University of Iceland, Hananja plc has developed an easy-to-use rectal enema that contains a combination of required drugs. This product does not depend on the child being alert and able to swallow. This product will also allow the treatment to be carried out in rural areas, where access to hospital settings is limited.

Epilepsy

Epilepsy is affecting around 50 million people worldwide, which makes it one of the most common neurological diseases. It affects people of all ages, and the risk of premature death is about 3 times higher, than in the general population. According to WHO, about 80% of people with epilepsy live in low- and middle-income countries, where most of them do not have access to treatment. Their lives are often impacted by stigma, discrimination, and human rights violations. In many countries people with epilepsy are regarded as being possessed with evil spirits. According to data from other countries, it is possible to give 70%

of epileptics, a seizure free life with effective medicines. Rephaiah wants to provide these children (and adults) a quality life without seizures.

Postpartum Hemorrhage

Each year, millions of women experience postpartum haemorrhage (PPH) and the global maternal mortality, because of this is estimated to be 223 maternal deaths per 100,000 live births (in 2020). This accounts for 20% of all maternal deaths reported globally.

 

This preventable and treatable condition remains one of the leading causes of maternal death worldwide, despite decades of work and proven life-saving interventions. Unfortunately, progress in reducing the mortality has stalled.

Hananja is currently working on developing a product that can be used to prevent PPH in women, or as a prophylactic treatment immediately after labor

Fungal Skin Infections (in children)

“Emerging from the shadows of the bacterial antimicrobial resistance pandemic, fungal infections are growing, and are ever more resistant to treatments, becoming a public health concern worldwide.” according to Dr Hanan Balkhy, WHO Assistant Director-General.

 

Children’s skin is much more susceptible to fungal skin infection, than adults, due to the fatty acid composition. Which is why children often have severe infections, their skin covered with fungi. The Icelandic company Capretto, has developed antimicrobial treatment based on antibiotic lipids, found in human breast milk (as well as in coconuts), that kills pathogenic viruses, bacteria and fungal infections. This product is needed on the African continent, as well as in India and Asia. Together with Kamuzu University of Health Sciences, this treatment has been shown to be more effective than conventional fungal medicines.

Schistosomiasis (Bilharzia)

Schistosomiasis (bilharzia, snail fever) is the second highest disease burden after malaria. Infants and children under the age of 6 years are currently not being included in mass drug administration campaigns against schistosomiasis. According to the WHO, the reason is due to the lack of a suitable pediatric formulation of the drug, praziquantel, for these age groups. Many areas in Sub-Saharan Africa have a high prevalence of schistosomiasis in young children, especially in the areas where there is a lake, slow-flowing rivers, and rice fields. When children do not receive treatment, the disease will cause impaired cognitive and memory development and growth, and they become a high burden to society. Additionally, studies have shown that people (girls) infected with bilharzia are four times more likely to become infected with HIV. Therefore, reports suggest that if HIV is to be eliminated, we need to start fighting and eradicating schistosomiasis.

The Icelandic companies Hananja and Capretto are currently exploring the possibilities to eliminate the schistosomal eggs from the vaginal tract, using the antimicrobial lipids, releasing women and small girls from the pain and irritation from the vaginal tract which symptoms are similar to sexually transmitted diseases and are often regarded as such (even in children).

_1400206.jpg

© 2024 by Rephaiah 

  • Facebook
  • Instagram
bottom of page